Nicolas Girard

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 19

Top Topics

Tyrosine Kinase

Clinical Practice

Small Cell Lung Cancer

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Advances in therapy

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Luis G Paz-Ares, Oscar Juan Vidal, Giannis S Mountzios, Enriqueta Felip Font, Niels Reinmuth, Filippo de Marinis, Nicolas Girard, Vipul M Patel, Takayuki Takahama, Scott P Owen, Douglas M Reznick, Firas B Badin, Irfan Cicin, Sabeen Mekan, Riddhi Patel, Eric Zhang, Divyadeep Karumanchi, Marina-Chiara Garassino
Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (24) (2024)
D Ross Camidge, Jair Bar, Hidehito Horinouchi, Jonathan Wade Goldman, Fedor V Moiseyenko, Elena Filippova, Irfan Cicin, Tudor Ciuleanu, Nathalie Daaboul, Chunling Liu, Penelope Bradbury, Mor Moskovitz, Nuran Katgi, Pascale Tomasini, Alona Zer Kuch, Nicolas Girard, Kristof Cuppens, Ji-Youn Han, Shang-Yin Wu, Shobhit Baijal, Aaron S Mansfield, Allen Chung-Cheng Huang, Kazumi Nishino, Se-Hoon Lee, David Planchard, Christina Baik, Martha Li, Peter Ansell, Summer Xia, Ellen Bolotin, Jim Looman, Christine Ratajczak, Shun Lu
Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein-Overexpressing Advanced Nonsquamous EGFR -Wildtype Non-Small Cell Lung Cancer in the Phase II LUMINOSITY Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
Myung-Ju Ahn, Kentaro Tanaka, Luis G Paz-Ares, Robin Cornelissen, Nicolas Girard, Elvire Pons-Tostivint, David Vicente Baz, Shunichi Sugawara, Manuel Cobo, Maurice Pérol, Céline Mascaux, Elena V Poddubskaya, Satoru Kitazono, Hidetoshi Hayashi, Min Hee Hong, Enriqueta Felip Font, Richard Hall, Oscar Juan Vidal, Daniel Brungs, Shun Lu, Marina-Chiara Garassino, Michael J Chargualaf, Yong Zhang, Paul Howarth, Deise Uema, Aaron E Lisberg, Jacob M Sands, null null
Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
D Ross Camidge, Jair Bar, Hidehito Horinouchi, Jonathan Wade Goldman, Fedor V Moiseyenko, Elena Filippova, Irfan Cicin, Tudor Ciuleanu, Nathalie Daaboul, Chunling Liu, Penelope Bradbury, Mor Moskovitz, Nuran Katgi, Pascale Tomasini, Alona Zer Kuch, Nicolas Girard, Kristof Cuppens, Ji-Youn Han, Shang-Yin Wu, Shobhit Baijal, Aaron S Mansfield, Allen Chung-Cheng Huang, Kazumi Nishino, Se-Hoon Lee, David Planchard, Christina Baik, Martha Li, Peter Ansell, Summer Xia, Ellen Bolotin, Jim Looman, Christine Ratajczak, Shun Lu
Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein-Overexpressing Advanced Nonsquamous EGFR -Wildtype Non-Small Cell Lung Cancer in the Phase II LUMINOSITY Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
D Ross Camidge, Jair Bar, Hidehito Horinouchi, Jonathan Wade Goldman, Fedor V Moiseyenko, Elena Filippova, Irfan Cicin, Tudor Ciuleanu, Nathalie Daaboul, Chunling Liu, Penelope Bradbury, Mor Moskovitz, Nuran Katgi, Pascale Tomasini, Alona Zer Kuch, Nicolas Girard, Kristof Cuppens, Ji-Youn Han, Shang-Yin Wu, Shobhit Baijal, Aaron S Mansfield, Allen Chung-Cheng Huang, Kazumi Nishino, Se-Hoon Lee, David Planchard, Christina Baik, Martha Li, Peter Ansell, Summer Xia, Ellen Bolotin, Jim Looman, Christine Ratajczak, Shun Lu
Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein-Overexpressing Advanced Non-Squamous EGFR-Wildtype NSCLC in the Phase 2 LUMINOSITY Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Luis G Paz-Ares, Oscar Juan Vidal, Giannis S Mountzios, Enriqueta Felip Font, Niels Reinmuth, Filippo de Marinis, Nicolas Girard, Vipul M Patel, Takayuki Takahama, Scott P Owen, Douglas M Reznick, Firas B Badin, Irfan Cicin, Sabeen Mekan, Riddhi Patel, Eric Zhang, Divyadeep Karumanchi, Marina-Chiara Garassino
Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
D Ross Camidge, Jair Bar, Hidehito Horinouchi, Jonathan Wade Goldman, Fedor V Moiseyenko, Elena Filippova, Irfan Cicin, Tudor Ciuleanu, Nathalie Daaboul, Chunling Liu, Penelope Bradbury, Mor Moskovitz, Nuran Katgi, Pascale Tomasini, Alona Zer Kuch, Nicolas Girard, Kristof Cuppens, Ji-Youn Han, Shang-Yin Wu, Shobhit Baijal, Aaron S Mansfield, Allen Chung-Cheng Huang, Kazumi Nishino, Se-Hoon Lee, David Planchard, Christina Baik, Martha Li, Peter Ansell, Summer Xia, Ellen Bolotin, Jim Looman, Christine Ratajczak, Shun Lu
Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein-Overexpressing Advanced Non-Squamous EGFR-Wildtype NSCLC in the Phase 2 LUMINOSITY Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
D Ross Camidge, Jair Bar, Hidehito Horinouchi, Jonathan Wade Goldman, Fedor V Moiseyenko, Elena Filippova, Irfan Cicin, Tudor Ciuleanu, Nathalie Daaboul, Chunling Liu, Penelope Bradbury, Mor Moskovitz, Nuran Katgi, Pascale Tomasini, Alona Zer Kuch, Nicolas Girard, Kristof Cuppens, Ji-Youn Han, Shang-Yin Wu, Shobhit Baijal, Aaron S Mansfield, Allen Chung-Cheng Huang, Kazumi Nishino, Se-Hoon Lee, David Planchard, Christina Baik, Martha Li, Peter Ansell, Summer Xia, Ellen Bolotin, Jim Looman, Christine Ratajczak, Shun Lu
Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein-Overexpressing Advanced Nonsquamous EGFR -Wildtype Non-Small Cell Lung Cancer in the Phase II LUMINOSITY Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
D Ross Camidge, Jair Bar, Hidehito Horinouchi, Jonathan Wade Goldman, Fedor V Moiseyenko, Elena Filippova, Irfan Cicin, Tudor Ciuleanu, Nathalie Daaboul, Chunling Liu, Penelope Bradbury, Mor Moskovitz, Nuran Katgi, Pascale Tomasini, Alona Zer Kuch, Nicolas Girard, Kristof Cuppens, Ji-Youn Han, Shang-Yin Wu, Shobhit Baijal, Aaron S Mansfield, Allen Chung-Cheng Huang, Kazumi Nishino, Se-Hoon Lee, David Planchard, Christina Baik, Martha Li, Peter Ansell, Summer Xia, Ellen Bolotin, Jim Looman, Christine Ratajczak, Shun Lu
Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein-Overexpressing Advanced Nonsquamous EGFR -Wildtype Non-Small Cell Lung Cancer in the Phase II LUMINOSITY Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
D Ross Camidge, Jair Bar, Hidehito Horinouchi, Jonathan Wade Goldman, Fedor V Moiseyenko, Elena Filippova, Irfan Cicin, Tudor Ciuleanu, Nathalie Daaboul, Chunling Liu, Penelope Bradbury, Mor Moskovitz, Nuran Katgi, Pascale Tomasini, Alona Zer Kuch, Nicolas Girard, Kristof Cuppens, Ji-Youn Han, Shang-Yin Wu, Shobhit Baijal, Aaron S Mansfield, Allen Chung-Cheng Huang, Kazumi Nishino, Se-Hoon Lee, David Planchard, Christina Baik, Martha Li, Peter Ansell, Summer Xia, Ellen Bolotin, Jim Looman, Christine Ratajczak, Shun Lu
Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein-Overexpressing Advanced Nonsquamous EGFR -Wildtype Non-Small Cell Lung Cancer in the Phase II LUMINOSITY Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
Luis G Paz-Ares, Oscar Juan Vidal, Giannis S Mountzios, Enriqueta Felip Font, Niels Reinmuth, Filippo de Marinis, Nicolas Girard, Vipul M Patel, Takayuki Takahama, Scott P Owen, Douglas M Reznick, Firas B Badin, Irfan Cicin, Sabeen Mekan, Riddhi Patel, Eric Zhang, Divyadeep Karumanchi, Marina-Chiara Garassino
Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Luis G Paz-Ares, Oscar Juan Vidal, Giannis S Mountzios, Enriqueta Felip Font, Niels Reinmuth, Filippo de Marinis, Nicolas Girard, Vipul M Patel, Takayuki Takahama, Scott P Owen, Douglas M Reznick, Firas B Badin, Irfan Cicin, Sabeen Mekan, Riddhi Patel, Eric Zhang, Divyadeep Karumanchi, Marina-Chiara Garassino
Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Christos Chouaid, Lise Bosquet, Nicolas Girard, Anna Kron, Matthias Scheffler, Frank Griesinger, Martin Sebastian, Jose Trigo, Santiago Viteri, Craig S Knott, Bernardo Rodrigues, Nora Rahhali, Jedelyn Cabrieto, Joris Diels, Nolen J Perualila, Claudio A Schioppa, Jan Sermon, Raphael Toueg, Nicole Erdmann, Janka Mielke, Mehregan Nematian-Samani, Cristina Martin-Fernandez, Innocent Pfaira, Tracy Li, Parthiv Mahadevia, Jürgen Wolf
An Adjusted Treatment Comparison Comparing Amivantamab Versus Real-World Clinical Practice in Europe and the United States for Patients with Advanced Non-Small Cell Lung Cancer with Activating Epidermal Growth Factor Receptor Exon 20 Insertion Mutations. Advances in therapy 40 (3) (2023)
Christos Chouaid, Lise Bosquet, Nicolas Girard, Anna Kron, Matthias Scheffler, Frank Griesinger, Martin Sebastian, Jose Trigo, Santiago Viteri, Craig S Knott, Bernardo Rodrigues, Nora Rahhali, Jedelyn Cabrieto, Joris Diels, Nolen J Perualila, Claudio A Schioppa, Jan Sermon, Raphael Toueg, Nicole Erdmann, Janka Mielke, Mehregan Nematian-Samani, Cristina Martin-Fernandez, Innocent Pfaira, Tracy Li, Parthiv Mahadevia, Jürgen Wolf
An Adjusted Treatment Comparison Comparing Amivantamab Versus Real-World Clinical Practice in Europe and the United States for Patients with Advanced Non-Small Cell Lung Cancer with Activating Epidermal Growth Factor Receptor Exon 20 Insertion Mutations. Advances in therapy (2023)
Christos Chouaid, Lise Bosquet, Nicolas Girard, Anna Kron, Matthias Scheffler, Frank Griesinger, Martin Sebastian, Jose Trigo, Santiago Viteri, Craig S Knott, Bernardo Rodrigues, Nora Rahhali, Jedelyn Cabrieto, Joris Diels, Nolen J Perualila, Claudio A Schioppa, Jan Sermon, Raphael Toueg, Nicole Erdmann, Janka Mielke, Mehregan Nematian-Samani, Cristina Martin-Fernandez, Innocent Pfaira, Tracy Li, Parthiv Mahadevia, Jürgen Wolf
An Adjusted Treatment Comparison Comparing Amivantamab Versus Real-World Clinical Practice in Europe and the United States for Patients with Advanced Non-Small Cell Lung Cancer with Activating Epidermal Growth Factor Receptor Exon 20 Insertion Mutations. Advances in therapy 40 (3) (2023)
Christos Chouaid, Lise Bosquet, Nicolas Girard, Anna Kron, Matthias Scheffler, Frank Griesinger, Martin Sebastian, Jose Trigo, Santiago Viteri, Craig S Knott, Bernardo Rodrigues, Nora Rahhali, Jedelyn Cabrieto, Joris Diels, Nolen J Perualila, Claudio A Schioppa, Jan Sermon, Raphael Toueg, Nicole Erdmann, Janka Mielke, Mehregan Nematian-Samani, Cristina Martin-Fernandez, Innocent Pfaira, Tracy Li, Parthiv Mahadevia, Jürgen Wolf
An Adjusted Treatment Comparison Comparing Amivantamab Versus Real-World Clinical Practice in Europe and the United States for Patients with Advanced Non-Small Cell Lung Cancer with Activating Epidermal Growth Factor Receptor Exon 20 Insertion Mutations. Advances in therapy 40 (3) (2023)
Christos Chouaid, Lise Bosquet, Nicolas Girard, Anna Kron, Matthias Scheffler, Frank Griesinger, Martin Sebastian, Jose Trigo, Santiago Viteri, Craig S Knott, Bernardo Rodrigues, Nora Rahhali, Jedelyn Cabrieto, Joris Diels, Nolen J Perualila, Claudio A Schioppa, Jan Sermon, Raphael Toueg, Nicole Erdmann, Janka Mielke, Mehregan Nematian-Samani, Cristina Martin-Fernandez, Innocent Pfaira, Tracy Li, Parthiv Mahadevia, Jürgen Wolf
An Adjusted Treatment Comparison Comparing Amivantamab Versus Real-World Clinical Practice in Europe and the United States for Patients with Advanced Non-Small Cell Lung Cancer with Activating Epidermal Growth Factor Receptor Exon 20 Insertion Mutations. Advances in therapy 40 (3) (2023)
John A Grout, Philémon Sirven, Andrew M Leader, Shrisha Maskey, Eglantine Hector, Isabelle Puisieux, Fiona Steffan, Evan Cheng, Navpreet Tung, Mathieu Maurin, Romain Vaineau, Lea Karpf, Martin Plaud, Anne-Laure Begue, Koushik Ganesh, Jérémy Mesple, María Casanova-Acebes, Alexandra Tabachnikova, Shilpa Keerthivasan, Alona Lansky, Jessica Le Berichel, Laura Walker, Adeeb H Rahman, Sacha Gnjatic, Nicolas Girard, Marine Lefevre, Diane Damotte, Julien Adam, Jerome Christophe Martin, Andrea Wolf, Raja M Flores, Mary Beth Beasley, Rachana N Pradhan, Sören Müller, Thomas U Marron, Shannon J Turley, Miriam Merad, Ephraim Kenigsberg, Hélène Salmon
Spatial Positioning and Matrix Programs of Cancer-Associated Fibroblasts Promote T-cell Exclusion in Human Lung Tumors. Cancer discovery 12 (11) (2022)
Nicolas Girard, Clémence Basse, Alexa Schrock, Shakti Ramkissoon, Keith Killian, Jeffrey S Ross
Comprehensive Genomic Profiling of 274 Thymic Epithelial Tumors Unveils Oncogenic Pathways and Predictive Biomarkers. The oncologist 27 (11) (2022)